Your session is about to expire
← Back to Search
Lenalidomide + Rituximab for Chronic Lymphocytic Leukemia
Study Summary
This trial will study the effectiveness of lenalidomide and rituximab in treating CLL.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.I can take care of myself and perform daily activities.My kidney function is good, with creatinine at or below 2mg/dL.My liver functions, including bilirubin and ALT levels, are within normal limits.I am allergic to lenalidomide, thalidomide derivatives, or rituximab.My blood test shows over 55% prolymphocytes, indicating prolymphocytic leukemia.I do not have any serious health issues that would make joining this study unsafe for me.I have not had a blood clot in my legs or lungs in the last 6 months.I have CLL/SLL and need treatment but can't or won't use chemoimmunotherapy, or I've had it before and it's come back.I've been cancer-free for 3 years, except for minor skin cancers or early-stage cervical or breast cancer.I must follow strict birth control and pregnancy testing if I'm of childbearing age and taking lenalidomide.I was treated for tuberculosis in the last 5 years or recently exposed to it.
- Group 1: Prior Treatment Any Age
- Group 2: Untreated 65 +
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are some diseases that Rituximab has been known to improve?
"Rituximab is a medication used to diffuse large b-cell lymphoma (dlbcl), as well as certain other conditions like b-cell lymphomas and polyangium."
Rituximab: How great is the threat it poses to human health?
"There is some data supporting Rituximab's safety, but none to suggest it is effective. It received a score of 2."
Are we looking for more participants in this clinical trial at the moment?
"The clinical trial described is not presently looking for subjects. The study was initially posted on December 12, 2011 and was last edited on October 11, 2020. Even though this particular research project isn't happening right now, there are 3578 other trials that are actively recruiting patients."
How many individuals are part of this clinical trial currently?
"This study is no longer recruiting patients. The listing was created on December 12th, 2011 and last updated on October 11th, 2020. For those looking for other studies, there are 2950 trials related to leukemia and 628 involving Rituximab that are still recruiting participants."
Share this study with friends
Copy Link
Messenger